Literature DB >> 7495498

Physiology and pathophysiology of complement: progress and trends.

B P Morgan1.   

Abstract

The complement system comprises a family of at least 20 plasma and membrane proteins that interact in a tightly regulated cascade system to destroy invading bacteria and prevent the deposition of immune complexes in the tissues. This brief review addresses the basic mechanisms of complement activation and control and describes the active fragments produced during complement activation. The biological importance of the complement system is amply illustrated in patients with complement deficiencies, who are susceptible to bacterial infections and immune complex diseases. The involvement of complement in other immunological diseases is an expanding area of clinical research, supported by the development of new assays for the identification of complement activation. This area is discussed here with particular reference to neurological diseases. A promising new prospect involves the use of complement inhibitory molecules in therapy of complement-mediated disease and this exciting area is also discussed. Novel physiological roles of complement also are being revealed and new evidence that complement and complement receptors play an important role in reproduction is summarized. It is hoped that this brief overview will convey some of the enthusiasm currently pervading research in this underappreciated area of immunology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495498     DOI: 10.3109/10408369509084686

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  28 in total

1.  In situ localization of C3 synthesis in experimental acute renal allograft rejection.

Authors:  J R Pratt; K Abe; M Miyazaki; W Zhou; S H Sacks
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Impaired volume regulation is the mechanism of excitotoxic sensitization to complement.

Authors:  Li Shen Loo; James O McNamara
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 3.  The future use of complement inhibitors for the treatment of neurological diseases.

Authors:  E G McGeer; P L McGeer
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

4.  Complement and contact activation in term neonates after fetal acidosis.

Authors:  J Sonntag; M H Wagner; E Strauss; M Obladen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

Review 5.  Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.

Authors:  Jessica N Cooke Bailey; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

6.  Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function.

Authors:  N K Rushmere; S Tomlinson; B P Morgan
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.

Authors:  T Miwa; X Sun; R Ohta; N Okada; C L Harris; B P Morgan; W C Song
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

9.  Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.

Authors:  Zhi-Qi Xiong; Weihua Qian; Katsuaki Suzuki; James O McNamara
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.

Authors:  K M Cunnion; P S Hair; E S Buescher
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.